About the Studies

The SOTA studies are evaluating an investigational oral tablet that may help manage your blood glucose levels.

Why Participate?

This investigational oral tablet combined with diet and exercise, may help manage blood glucose levels in people with Type 2 Diabetes (T2D).

Am I Eligible?

A clinical research team member will help determine if you meet all necessary criteria to participate.

sect1-mb

sect1-mb

About the Studies

Hundreds of millions of people have diabetes worldwide– and those numbers continue to climb. Over 90% of people with diabetes have Type 2 Diabetes (T2D). It is one of the leading causes of heart disease, stroke, blindness, kidney disease, amputation and death.

Diet, exercise, and education are important in the management of T2D, but many people also require drug therapy to manage their illness. Maintaining blood glucose levels within the recommended range is a difficult goal to achieve without increasing your risk of hypoglycemia (low blood sugar).

Participants will be required to attend regular office visits throughout the duration of the SOTA studies. You will be given glucose monitoring supplies and asked to record your blood glucose levels and any symptoms you might be having in a diary. Participants will be required to fast, or go without food for 8 hours, prior to some visits during the study. You may also have the following assessments evaluated: physical exam, vital signs, blood and urine tests; and diet, exercise, and health education.

The SOTA studies are evaluating an investigational oral tablet that may help manage your blood glucose levels.

In the SOTA-GLIM study, you will randomly be assigned to receive the investigational oral tablet, glimepiride, or a placebo. You will be provided with kits containing either the study drug or placebo tablets, as well as, kits containing either glimepiride or placebo capsules. The oral tablets and capsules will be taken once before the first meal of the day. The placebo has no active drug in it. Neither you nor the person administering the drugs will know if you are receiving the study drug, glimepiride, or the placebo.

sect1-mb

sect2-mb

Why Participate?

BENEFITS

This investigational oral tablet when combined with diet and exercise may help manage blood glucose levels in people with Type 2 Diabetes (T2D). Additionally, the knowledge gained from the SOTA studies may help other people with T2D in the future.

RISKS

The clinical research team will discuss all study risks with you and answer any additional questions you may have. Eligible participants will receive study related medical care at no cost.

sect3-mb

Am I Eligible?

Only the clinical research study staff can fully determine if you qualify to enroll in one of these studies. However, answering these 3 questions now can help determine your eligibility:

Am I Eligible?

Only the clinical research study staff can fully determine if you qualify to enroll in one of these studies. However, answering these 3 questions now can help determine your eligibility: